Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Coherus: Interchangeability ‘A Melting Ice Cube,’ Price And Supply Key
FDA-Approved Yusimry Biosimilar Device ‘Will Look Nearly Identical’
Mar 21 2022
•
By
Dean Rudge
Coherus wants to capture at least a 10% volume share • Source: Alamy
More from Biosimilars
More from Products